ProText Mobility Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2012
2013
2016
2017
2018
Sales/Revenue
10.60
0.60
-
-
321.50
Cost of Goods Sold (COGS) incl. D&A
115.90
-
-
-
-
Gross Income
105.30
0.60
-
-
-
SG&A Expense
1,336.80
927.90
290.40
499.60
321.50
EBIT
1,442.10
927.30
-
499.60
321.50
Unusual Expense
75.90
11.20
-
-
110.50
Interest Expense
651.70
508.80
-
49.00
81.10
Pretax Income
2,169.80
1,447.40
290.40
548.60
513.10
Consolidated Net Income
2,169.80
1,447.40
290.40
548.60
513.10
Net Income
2,169.80
1,447.40
290.40
548.60
513.10
Net Income After Extraordinaries
2,169.80
1,447.40
290.40
548.60
513.10
Net Income Available to Common
2,641.20
1,918.80
290.40
548.60
513.10
EPS (Basic)
8.94
2.26
0.00
0.00
-
Basic Shares Outstanding
295.40
850.60
1,946,690.30
3,991,316.00
4,324,316
EPS (Diluted)
8.94
2.26
0.00
0.00
-
Diluted Shares Outstanding
295.40
850.60
1,946,690.30
3,991,316.00
4,324,316
EBITDA
1,326.10
927.30
290.40
499.60
321.50
Preferred Dividends
471.50
471.50
-
-
-

About ProText Mobility

View Profile
Address
2255 Glades Road
Boca Raton Florida 33431
United States
Employees -
Website http://www.Protextm.co
Updated 07/08/2019
ProText Mobility, Inc. engages in the development of pharmaceutical applications for botanical drugs. It has license to develop Phytofare, which is a bioavailable extract produced from live green tea leaves that has been clinically proven in double-blind human trials to have ten-times greater bioavailability over generic extract. The company was founded on September 5, 2001 and is headquartered in Boca Raton, FL.